Manufacturing Technician I
AbbVie
Summary
This is our Compounding B1 Shift: 6am-6:30pm Thursday - Saturday & every other Wednesday
Job description
Job Description
This is our Compounding B1 Shift: 6am-6:30pm Thursday - Saturday & every other Wednesday
Performs functions associated with cGMP manufacturing operations within the biologics production facility, including working with engineers in set-up and calibration tasks, as well as performing rework and quality testing related to the production of parts, components and final materials. Uses sophisticated programs (such as LIMS, SAP, automated control systems, etc.) to collect and evaluate operating data, which can be used to conduct on-line adjustments to products, instruments or equipment. Determines and may assist in developing methods and procedures to control or modify the manufacturing process.
Responsibilities
- Shipping finished materials.
- Maintaining inventory levels.
- Sampling of in process and raw materials.
- Running glass washer / autoclave.
- Buffer / media preparation.
- Equipment preparation (CIP / SIP).
- Cell culture (from vial thaw to production scale).
- Column chromatography.
- Tangential flow filtration.
Requirements
- High School diploma (or equivalent experience), with 2+ years experience
- Associates degree in science, with 1+ years relevant experience
- Bachelor's Degree with 0+ year relevant experience
- Acquires job skills and learns company policies and procedures to complete routine tasks
- Works on assignments that are routine in nature, requiring limited judgment
- Has the ability to recognize when accepted practices are deviated from
- Normally receives detailed instructions on all work
- Works under close supervision
Benefits
- Paid Time Off
- Vacation
- Holidays
- Sick Leave
- Medical Insurance
- Dental Insurance
- Vision Insurance
- 401(k)
- Short-Term Incentive Programs
Company overview
AbbVie is a global biopharmaceutical company that discovers, develops, and markets advanced therapies for some of the world's most complex and serious diseases. Founded in 2013 as a spin-off from Abbott Laboratories, AbbVie has established itself as a leader in immunology, oncology, neuroscience, eye care, and virology. The company's flagship product, Humira (adalimumab), was one of the world's top-selling drugs for treating autoimmune conditions like rheumatoid arthritis and Crohn's disease. AbbVie maintains a robust pipeline of innovative medicines and has expanded its portfolio through strategic acquisitions, including Allergan in 2020. With research facilities across the United States and globally, AbbVie focuses on advancing science to improve patient outcomes while maintaining strong commercial operations worldwide. The company operates with a patient-centric approach and invests significantly in research and development to address unmet medical needs across multiple therapeutic areas.